ARCpoint Inc. (ARC.V)
| Previous Close | 0.0950 |
| Open | 0.0950 |
| Bid | 0.0900 x N/A |
| Ask | 0.0950 x N/A |
| Day's Range | 0.0900 - 0.0950 |
| 52 Week Range | 0.0800 - 0.3000 |
| Volume | |
| Avg. Volume | 14,852 |
| Market Cap | 9.524M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.ARCpoint Reports Full Year 2023 Earnings
ARCpoint ( CVE:ARC ) Full Year 2023 Results Key Financial Results Revenue: US$6.67m (down 39% from FY 2022). Net loss...
GlobeNewswireARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2023 Q4 AND FULL YEAR FINANCIAL RESULTS
Greenville, South Carolina, April 29, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) a leading US-based franchise system providing drug testing, alcohol screening, DNA and direct to consumer (“DTC”) clinical lab testing services, announces that it will host a conference call at 4pm Eastern time, Wednesday, May 1, 2024 to review the Company’s 2023 full year and fourth quarter, ending December 31, 2023 results. The dial-in number for the conference call is as foll
- GlobeNewswire
ARCPOINT ANNOUNCES CLOSING OF US$1.1 MILLION NON-BROKERED PRIVATE PLACEMENT
Not for Dissemination in the United States or through U.S. Newswire Services Greenville, South Carolina, Jan. 22, 2024 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) is pleased to announce that it has closed its previously announced non-brokered private placement (the “Offering”) for gross proceeds of US$1,100,000, through the sale of 11,000,000 Class A subordinate voting shares of the Company (each, a “Share”) at a price of US$0.10 per Share. The net proceeds from t
